Skip to main content
Home
FULL MENU Close Menu
Home
Home

Madelaine (Mattie) Feldman, MD

Opinion

A little education goes a long way for advocacy

Author:
Madelaine (Mattie) Feldman, MD
Publish date: March 16, 2023

Fellows who learned about the influence that pharmacy benefit managers have on drug costs and access at the Coalition of State Rheumatology...

  • Read More

Opinion

Unintended consequences of perfectly good programs and policies

Author:
Madelaine (Mattie) Feldman, MD
Publish date: January 18, 2023

Dr. Madelaine Feldman describes the unintended consequences of what were thought to be good ideas at the time: Giving safe harbor from the Anti-...

  • Read More

News

Use 2022’s advocacy successes and frustrations as a catalyst for the new year

Author:
Madelaine (Mattie) Feldman, MD
Publish date: November 14, 2022

Dr. Mattie Feldman looks back on the successes and frustrations with health policy legislation and regulation and insurance companies in 2022,...

  • Read More

News

Employers’ self-funded health plans can leave rheumatology patients vulnerable

Author:
Madelaine (Mattie) Feldman, MD
Publish date: September 20, 2022

The CSRO is developing a employer tool kit that educates employers with self-funded health plans about the pitfalls of some of their drug coverage...

  • Read More

Opinion

Who’s in charge here? Rheumatologists battle local Medicare policies threatening access, practice sustainability

Author:
Madelaine (Mattie) Feldman, MD
Publish date: July 21, 2022

Dr. Mattie Feldman explains the advocacy work that the Coalition of State Rheumatology Organizations and other groups are undertaking to address...

  • Read More

News

Will ‘gold card’ legislation and others rein in prior authorizations?

Author:
Madelaine (Mattie) Feldman, MD
Publish date: May 23, 2022

“Gold card” legislation already passed or in the works in several states has potential to reduce prior authorization burdens on clinicians, but...

  • Read More

Opinion

New law will awaken employers to health care’s ‘transparency gap’

Author:
Madelaine (Mattie) Feldman, MD
Publish date: March 16, 2022

Not only will the Consolidated Appropriation Act of 2020-21 help to eliminate much of the “transparency gap” in the system, but it may encourage...

  • Read More

News

Could stopping ‘thousand cuts’ by insurers and PBMs help rheumatology’s workforce shortage?

Author:
Madelaine (Mattie) Feldman, MD
Publish date: January 19, 2022

Efforts to report and address rheumatologists’ frustrations brought on by the profit-first, patient care–second...

  • Read More

News

Taking 2021’s rheumatology advocacy momentum into 2022

Author:
Madelaine (Mattie) Feldman, MD
Publish date: November 12, 2021

In the coming year, prepare to advocate to legislators for policies that prohibit payers from mandating the use of white bagging, brown bagging,...

  • Read More

Opinion

Beware patients’ health plans that skirt state laws on specialty drug access

Author:
Madelaine (Mattie) Feldman, MD
Publish date: September 20, 2021

Dr. Mattie Feldman calls on rheumatologists to take third-party administrators to task for convincing businesses that use self-funded health...

  • Read More

News

Legislative wins set groundwork for future success

Author:
Madelaine (Mattie) Feldman, MD
Publish date: July 16, 2021

Dr. Madelaine (Mattie) Feldman recounts recent advocacy wins across states in fighting copay accumulators, step therapy, and pharmacy benefit...

  • Read More

Opinion

How I got started in advocacy

Author:
Madelaine (Mattie) Feldman, MD
Publish date: May 12, 2021

Rheumatology News and the CSRO have partnered to keep rheumatologists regularly informed on the advocacy issues of the day.

  • Read More

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close